Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 3/20 | 0.53 |
| ▸ | ESR1 | P03372 | 2/20 | 0.53 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.53 |
| ▸ | TACR2 | P21452 | 2/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.53 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | SHBG | P04278 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.53 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.53 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.53 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.53 |
| ▸ | TST | Q16762 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6891878 | 1.00 | PTGS2 (0.53) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL28162722 | 1.00 | PTGS2 (0.53) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL3721561 | 1.00 | PTGS2 (0.53) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL29015687 | 1.00 | PTGS2 (0.53) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL3724287 | 1.00 | PTGS2 (0.53) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL28163200 | 1.00 | PTGS2 (0.53) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL3724269 | 1.00 | PTGS2 (0.53) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL3720679 | 1.00 | PTGS2 (0.53) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL21240657 | 1.00 | PTGS2 (0.53) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL3723631 | 1.00 | PTGS2 (0.53) | PTGS2ESR1ADRA2AADORA3TACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070141747-A1 | Electronic device fabrication process | XEROX CORPORATION | 2007-06-21 | — | — | US | claimed |
| EP-1433211-B1 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M INNOVATIVE PROPERTIES CO (US) | 2006-06-21 | — | — | EP | claimed |
| US-6864396-B2 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-03-08 | — | — | US | claimed |
| CN-1582506-A | Substituted pentacene semiconductors | 3M INNOVATIVE PROPERTIES CO (US) | 2005-02-16 | — | — | CN | claimed |
| US-20030105365-A1 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | 3M INNOVATIVE PROPERTIES COMPANY | 2003-06-05 | — | — | US | claimed |
| US-7651885-B2 | Electronic device fabrication process | XEROX CORPORATION (US) | 2010-01-26 | — | — | US | disclosed |
| US-20070141747-A1 | Electronic device fabrication process | XEROX CORPORATION | 2007-06-21 | — | — | US | disclosed |
| EP-1433211-B1 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M INNOVATIVE PROPERTIES CO (US) | 2006-06-21 | — | — | EP | disclosed |
| US-20050288522-A1 | Process for preparing pentacene derivatives | 3M INNOVATIVE PROPERTIES COMPANY | 2005-12-29 | — | — | US | disclosed |
| US-6974877-B2 | Process for preparing pentacene derivatives | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-12-13 | — | — | US | disclosed |
| CN-1592729-A | Process for preparing pentacene derivatives | 3M INNOVATIVE PROPERTIES CO (US) | 2005-03-09 | — | — | CN | disclosed |
| US-6864396-B2 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2005-03-08 | — | — | US | disclosed |
| CN-1582506-A | Substituted pentacene semiconductors | 3M INNOVATIVE PROPERTIES CO (US) | 2005-02-16 | — | — | CN | disclosed |
| EP-1433211-A2 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M Innovative Properties Company (US) | 2004-06-30 | — | — | EP | disclosed |
| US-20030105365-A1 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | 3M INNOVATIVE PROPERTIES COMPANY | 2003-06-05 | — | — | US | disclosed |
| US-20030100779-A1 | Process for preparing pentacene derivatives | 3M INNOVATIVE PROPERTIES COMPANY | 2003-05-29 | — | — | US | disclosed |
| US-20030097010-A1 | Process for preparing pentacene derivatives | 3M INNOVATIVE PROPERTIES COMPANY | 2003-05-22 | — | — | US | disclosed |
| WO-2003028125-A2 | SUBSTITUTED PENTACENE SEMICONDUCTORS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2003-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288522-A1 | Process for preparing pentacene derivatives | RARA, RARB, C9 | PTGS2 4030/4885ESR1 1433/4885ADRA2A 3347/4885 |
| US-20030097010-A1 | Process for preparing pentacene derivatives | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PCBP1, RARA | PTGS2 3492/4885ESR1 3161/4885ADRA2A 2931/4885 |
| US-20030105365-A1 | Comprise at least one substituent selected from electron-donating substituents, halogen substituents, and combinations thereof; organic thin-film transistors | ETV1, HTR3C, SLC43A1 | PTGS2 3271/4885ESR1 520/4885ADRA2A 806/4885 |
| US-20030100779-A1 | Process for preparing pentacene derivatives | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PCBP1, RARA | PTGS2 3492/4885ESR1 3161/4885ADRA2A 2931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.